Literature DB >> 35449634

Ceftriaxone-Induced Reversible Agranulocytosis: A Case Report and Review of Drug-Induced Agranulocytosis.

Farrukh Munir1, Hafiza Wajeeha Javaid1, Muhammad Burhan Majeed Rana2, Fatima Shaukat3.   

Abstract

In the modern era of medicine, agranulocytosis is a rare occurrence. Despite significant improvement in patient survival, it still carries significant mortality. Agranulocytosis is most commonly caused by chemotherapeutic agents and numerous non-chemo drugs. As it can develop anytime during treatment and patients can remain asymptomatic, frequent cell count monitoring is an essential tool to make a timely diagnosis. An appropriate drug switch, work up to rule out infection and granulocyte colony-stimulating factor (G-CSF) injection in high-risk cases is the management. The patient should be kept under observation till the resolution of agranulocytosis. We present a case of ceftriaxone-induced agranulocytosis which was completely reversible upon stoppage of drug and granulocyte colony-stimulating factor administration. The pathogenesis of ceftriaxone-induced agranulocytosis is unknown. It is suggested to occur either by an immunologic mechanism or because of direct drug toxicity.
Copyright © 2022, Munir et al.

Entities:  

Keywords:  bone marrow biospy; ceftriaxone induced aganulocytosis; drug induced agranulocytosis; g-csf; neutropenia

Year:  2022        PMID: 35449634      PMCID: PMC9012477          DOI: 10.7759/cureus.23226

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  35 in total

1.  Fluconazole-induced agranulocytosis with eosinophilia.

Authors:  A Wong-Beringer; K Shriner
Journal:  Pharmacotherapy       Date:  2000-04       Impact factor: 4.705

2.  Clinical presentation and management of drug-induced agranulocytosis.

Authors:  Emmanuel Andrès; Jacques Zimmer; Mustapha Mecili; Thierry Weitten; Martine Alt; Frédéric Maloisel
Journal:  Expert Rev Hematol       Date:  2011-04       Impact factor: 2.929

Review 3.  Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis.

Authors:  Alexander Johnston; Jack Uetrecht
Journal:  Expert Opin Drug Metab Toxicol       Date:  2014-11-26       Impact factor: 4.481

Review 4.  Anticonvulsant drugs and hematological disease.

Authors:  A Verrotti; A Scaparrotta; S Grosso; F Chiarelli; G Coppola
Journal:  Neurol Sci       Date:  2014-03-12       Impact factor: 3.307

5.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

6.  Oxygen-dependent killing of Staphylococcus aureus by human neutrophils.

Authors:  S W Edwards; J E Say; C A Hart
Journal:  J Gen Microbiol       Date:  1987-12

7.  Agranulocytosis from Outpatient Antimicrobial Treatment with Ceftriaxone: A Case Report.

Authors:  Yevgeniy Genchanok; Seda S Tolu; Heidy Wang; Shitij Arora
Journal:  Perm J       Date:  2019-06-21

8.  Antithyroid drug-induced agranulocytosis: special reference to normal white blood cell count agranulocytosis.

Authors:  Junichi Tajiri; Shiro Noguchi
Journal:  Thyroid       Date:  2004-06       Impact factor: 6.568

9.  The relationship between bone marrow characteristics and the clinical prognosis of antithyroid drug-induced agranulocytosis.

Authors:  Jing Yang; Jing Zhong; Xin-Hua Xiao; Ling-Zhi Zhou; Ya-Jun Chen; Jiang-Hua Liu; Ren-Xian Cao; Ge-Bo Wen
Journal:  Endocr J       Date:  2012-10-27       Impact factor: 2.349

10.  PECAM-1 is required for transendothelial migration of leukocytes.

Authors:  W A Muller; S A Weigl; X Deng; D M Phillips
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.